BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11072497)

  • 1. A case of primary drug resistant tuberculosis.
    Jeyakumar D
    Med J Malaysia; 2000 Mar; 55(1):129-31. PubMed ID: 11072497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Chen QL; Chen L; Yin JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in drug-resistant tuberculosis.
    Ghoshal AG; Mukherjee K
    J Assoc Physicians India; 1994 Apr; 42(4):348. PubMed ID: 7860576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis.
    Garner P; Holmes A
    Clin Evid; 2002 Jun; (7):747-56. PubMed ID: 12230701
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
    Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
    Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multidrug-resistant pulmonary tuberculosis cured by the regimen including thiacetazone].
    Wada M; Mizutani S; Nakajima Y; Ito K; Mitarai S; Hoshino H; Okumura M; Yoshiyama T; Ogata H
    Kekkaku; 2007 Jan; 82(1):33-7. PubMed ID: 17310780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
    Grishin MN; Svistov VV; Krivoshein IuS
    Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.
    Tabarsi P; Nooraki A; Mirsaeidi M; Amiri M; Baghaei P; Farnia P; Kazempour M; Heidarnazhad H; Alipanah N; Mansouri D; Masjedi MR
    Respirology; 2008 Jan; 13(1):108-11. PubMed ID: 18197919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodic or routine susceptibility testing in tuberculosis control.
    Kalk A
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):176-7; author reply 177-9. PubMed ID: 11931421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.